NCT00196859 - Study in Elderly Patients With Early Breast Cancer (ICE) | Biotech Hunter

Enrollment

1,500

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Breast Cancer

Interventions

DRUG

Ibandronate, Capecitabine

Ibandronate 50 mg p.o. daily or 6 mg i.v., q4W, 2yrs plus Capecitabine 2000 mg/m2 days 1-14 q d22 x6

DRUG

Ibandronate

Ibandronate 50 mg p.o. daily or 6 mg i.v., q4W, 2yrs

Trial Locations (1)

Prof. Dr. med. Ulrike Nitz, Mönchengladbach